#covid-19

Hati-Hati! Jangan Sembarangan Konsumsi Vitamin D

Vitamin D adalah jenis vitamin larut lemak yang menjadi nutrisi bagi tubuh dalam memperkuat sistem imun. Konsumsi vitamin D atau suplemennya dipercaya mampu memelihara daya tahan tubuh dari ancaman Covid-19. Vitamin D dapat mudah didapatkan dari sinar matahari dan asupan makanan, seperti minyak ikan, kuning telur, dan ikan. Menurut Dr Jo Ann E. Manson, Profesor HARVARD dalam artikel berjudul: Vitamin D, Miracle Drug: is it Science, or just Talk? , mereka memperingatkan  agar lebih hati- hati dalam soal penambahan Vitamin D. Nutrisi yang mengandung vitamin D dosis tinggi tidak benar-benar membuat orang lebih sehat, penambahan VITAMIN D hanya ketika dalam kondisi kekurangan Vitamin D. 

Celebrating Eid while Beware of XE Variant

  After two years of not celebrating Eid al-Fitr due to the pandemic, muslims can finally celebrate the end of fasting in the holy month of Ramadan. As a country with the largest muslim population in the world, the moment of this holiday is celebrated so lively with local traditions that we know as "Lebaran". As a tradition and part of Indonesian culture, Lebaran is strongly colored by the local atmosphere. Eid is marked by a large flow of going home (mudik). Millions of people flocked back to their hometowns using various modes of transportation. After Eid prayer, often held in open fields, people enjoy a variety of delicious dishes, followed by the tradition of visiting each other's relatives and neighbors, apologizing, and even the young paying respect to the elderly. Meanwhile, the children were busy choosing treats of various snacks and receiving Eid gifts from their parents and relatives. The atmosphere of Eid is full of brotherhood, delicious food, full of joy and full of blessings.

Asymptomatic COVID-19 Patient with a Subtle Hypercoagulable State and Fluctuating D-dimer Level

Abstract Background: COVID-19 can infect an asymptomatic person silently without any overt symptoms despite diffuse blood clots throughout the body. Clot formation is induced by COVID-19 associated coagulopathy that can cause a high mortality rate. D-dimer, a fairly decisive marker for the coagulopathy event, is physiologically a marker of the fibrinolysis process. The increase of D-dimers in COVID-19 cases must be followed up because it relates to the initiation of a cytokine storm. Case presentation: We report an asymptomatic patient with sudden D-dimer elevation who received anticoagulant therapy. After three days of heparin administration, D-dimer results became normal and anticoagulant therapy was stopped. However, on the 12th day, the D-dimer level rebounded back and was followed by an increase of hs-C-reactive protein, erythrocyte sedimentation rate, IL-6, although SARS-CoV-2 PCR result became negative. A hyperglycaemic reaction and a sudden increase of HbA1C was observed in the patient. After three weeks D-dimer had returned to normal levels, and so did the other markers. The patient recovered fully and still no symptoms were obvious.

Fatal, Covid-19 pada Komorbid Ginjal

UNAIR NEWS – Ahli Ginjal FK UNAIR Prof Djoko Santoso dr SpPD KGH PhD FINASIM menuturkan pasien Covid-19 dengan komorbid (penyakit penyerta) penyakit ginjal kronis (PGK) berisiko lebih tinggi terhadap fatalitas. “Sebuah penelitian di Italia melaporkan bahwa kejadian Covid-19 pada pasien PGK 10 kali lebih tinggi dari pada pada populasi umum. Sedangkan angka kematian pada pasien PGK dengan Covid-19 juga hampir 10 kali lipat dibanding populasi pasien PGK tanpa Covid-19,” jelasnya. Senada dengan data tersebut, Badan Nasional Penanggulangan Bencana (BNPB) juga mencatat bahwa pasien PGK memiliki risiko kematian akibat Covid-19 terbesar, yakni 13,7 kali lipat dibanding dengan orang yang tidak memiliki komorbid.

Severe Covid-19 infection in a kidney transplant recipient treated with lopinavir/ritonavir, hydroxychloroquine and dexamethasone

Abstract Severe COVID-19 infection management for a recipient of kidney transplant has debatable prognosis and treatment. We described the case of a COVID-19 infected 70 year old female, previously had renal transplantation in 2017. The patient took immunosuppressive agents as routine drugs for transplant recipient status and received lopinavir/ritonavir, hydroxychloroquine, and dexamethasone daily at the hospitalization. Specific question arises about renal transplant recipients being infected by COVID-19 - whether the infection will get worse compared to those without immunosuppresive agent. In this case, author decided to stop the immunosuppressive agent followed administration of combination lopinavir/ritonavir, hydroxychloroquine, and dexamethasone that gives a good clinical impact change to patient's condition after once getting worsened and mechanically ventilated.